These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 19014278)
1. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278 [TBL] [Abstract][Full Text] [Related]
2. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma. Gu LQ; Li FY; Zhao L; Liu Y; Zang XX; Wang TX; Chen HP; Ning G; Zhao YJ Thyroid; 2009 Apr; 19(4):347-54. PubMed ID: 19355825 [TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713 [TBL] [Abstract][Full Text] [Related]
4. Effect and Interactions of BRAF on Lymph Node Metastasis in Papillary Thyroid Carcinoma With Hashimoto Thyroiditis. Li P; Liu Y; Wei T; Wang X; Zhu J; Yang R; Gong Y; Zhao W J Clin Endocrinol Metab; 2024 Mar; 109(4):944-954. PubMed ID: 37967234 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: a systematic review with meta-analysis. Janicki L; Patel A; Jendrzejewski J; Hellmann A Front Endocrinol (Lausanne); 2023; 14():1273498. PubMed ID: 38047109 [TBL] [Abstract][Full Text] [Related]
6. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294 [TBL] [Abstract][Full Text] [Related]
7. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785 [TBL] [Abstract][Full Text] [Related]
8. Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma. Kim YS; Kim JS; Bae JS; Park WC World J Surg Oncol; 2013 May; 11():99. PubMed ID: 23687957 [TBL] [Abstract][Full Text] [Related]
9. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Ahn D; Heo SJ; Park JH; Kim JH; Sohn JH; Park JY; Park SK; Park J Acta Oncol; 2011 Nov; 50(8):1228-34. PubMed ID: 21871002 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis. Kim WW; Ha TK; Bae SK J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976 [TBL] [Abstract][Full Text] [Related]
11. MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse. Renaud F; Gnemmi V; Devos P; Aubert S; Crépin M; Coppin L; Ramdane N; Bouchindhomme B; d'Herbomez M; Van Seuningen I; Do Cao C; Pattou F; Carnaille B; Pigny P; Wémeau JL; Leteurtre E Thyroid; 2014 Sep; 24(9):1375-84. PubMed ID: 25012490 [TBL] [Abstract][Full Text] [Related]
12. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Fugazzola L; Puxeddu E; Avenia N; Romei C; Cirello V; Cavaliere A; Faviana P; Mannavola D; Moretti S; Rossi S; Sculli M; Bottici V; Beck-Peccoz P; Pacini F; Pinchera A; Santeusanio F; Elisei R Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573 [TBL] [Abstract][Full Text] [Related]
13. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors. Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049 [TBL] [Abstract][Full Text] [Related]
15. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present. Marotta V; Guerra A; Zatelli MC; Uberti ED; Di Stasi V; Faggiano A; Colao A; Vitale M Clin Endocrinol (Oxf); 2013 Nov; 79(5):733-8. PubMed ID: 23469895 [TBL] [Abstract][Full Text] [Related]
16. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer. Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729 [TBL] [Abstract][Full Text] [Related]
17. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240 [TBL] [Abstract][Full Text] [Related]
18. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Park YJ; Kim YA; Lee YJ; Kim SH; Park SY; Kim KW; Chung JK; Youn YK; Kim KH; Park DJ; Cho BY Head Neck; 2010 Jan; 32(1):38-45. PubMed ID: 19475551 [TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma. Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273 [TBL] [Abstract][Full Text] [Related]
20. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma]. Zhu XL; Zhou XY; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):270-4. PubMed ID: 16181547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]